A61K 38/1774
Immunoglobulin superfamily
Official title: {Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)}
A61K38/1774 (Immunoglobulin superfamily) appears on 874 US grants and 1,796 published applications in this corpus.
Search patents in A61K- Granted patents
- 874
- Published applications
- 1,796
- Assignees
- 742
- Inventors
- 2,914
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 5 |
| 2002 | 8 | 17 |
| 2003 | 5 | 12 |
| 2004 | 2 | 15 |
| 2005 | 3 | 15 |
| 2006 | 6 | 13 |
| 2007 | 7 | 19 |
| 2008 | 5 | 18 |
| 2009 | 9 | 21 |
| 2010 | 8 | 25 |
| 2011 | 4 | 28 |
| 2012 | 20 | 29 |
| 2013 | 13 | 37 |
| 2014 | 26 | 45 |
| 2015 | 17 | 56 |
| 2016 | 39 | 89 |
| 2017 | 43 | 83 |
| 2018 | 56 | 153 |
| 2019 | 77 | 142 |
| 2020 | 78 | 129 |
| 2021 | 64 | 166 |
| 2022 | 85 | 223 |
| 2023 | 63 | 170 |
| 2024 | 73 | 114 |
| 2025 | 80 | 94 |
| 2026 | 66 | 78 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of treatment of cancer or tumour29 Sep 2026US 12,746,272 B2
- CD5 chimeric antigen receptor for adoptive T cell therapy29 Sep 2026US 12,746,273 B2Baylor College of Medicine
- Histone deacetylase inhibitors for use in immunotherapy22 Sep 2026US 12,740,986 B2Viracta Subsidiary, Inc.
- Methods and agents for treating acute neuroinflammatory injury25 Aug 2026US 12,714,738 B2Implicit Bioscience Limited
- Process for producing donor-batched cells expressing a recombinant receptor11 Aug 2026US 12,703,733 B2Juno Therapeutics, Inc.
- Methods of decreasing pathological neuroinflammation8 Oct 2026US 2026/0306585 A1Washington University
- Materials and methods for increasing immune responses within a mammal8 Oct 2026US 2026/0306668 A1Mayo Foundation for Medical Education and Research
- Composition comprising an antibody which binds to human srrm2 present on the cell surface of a target cell8 Oct 2026US 2026/0308237 A1Eximmium Biotechnologies GmbH
- Therapeutic circular dna forms1 Oct 2026US 2026/0294957 A1Flagship Pioneering Innovations Vii, LLC
- Hdac inhibitors for use with nk cell based therapies24 Sep 2026US 2026/0284060 A9NantKwest, Inc.
Most cited
By later US patents
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1328US 7,595,048 B2Ono Pharmaceutical Co., Ltd. · 2009
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014
- Immunopotentiative composition237US 8,728,474 B2Ono Pharmaceutical Co., Ltd. · 2014
- Methods for treatment of cancer216US 8,916,381 B1The Trustees of the University of Pennyslvania · 2014